Eckert & Ziegler: Personnel Changes in the Management. Changes in the Executive Board and Supervisory Board.
EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG
/ Key word(s): Personnel
Berlin, November 21, 2023. Dr. Hakim Bouterfa, Executive Board member of Eckert & Ziegler AG and responsible for clinical development, will leave the Executive Board of Eckert & Ziegler AG at the end of the year and in future will concentrate exclusively on his tasks as Executive Board member of the Eckert & Ziegler subsidiary Pentixapharm AG (PTX). There he will be supported by Dr. Dirk Pleimes and Anna Steeger, who have been newly appointed to the Executive Board of Pentixapharm AG. Following the consolidation of all clinical activities of the Eckert & Ziegler Group within or below PTX in recent months and following the decision to split-off PTX from the Group, Eckert & Ziegler AG no longer requires the position for clinical development within the Executive Board.
21.11.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | Eckert & Ziegler Strahlen- und Medizintechnik AG |
Robert-Rössle-Str.10 | |
13125 Berlin | |
Germany | |
Phone: | +49 30 941084-138 |
Fax: | +49 30 941084-112 |
E-mail: | karolin.riehle@ezag.de |
Internet: | www.ezag.de |
ISIN: | DE0005659700 |
WKN: | 565970 |
Indices: | SDAX, |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1778651 |
End of News | EQS News Service |
Editor Details
-
Company:
- EQS Newsfeed
- Website: